The insider sales are too small to signal a bearish view. Monitor for any material changes in Incyte's pipeline or upcoming earnings, but this cluster alone does not warrant a trading action.
INCY drugs
INCY drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 21 $117.39entry
- T+1 · 4mo ago −1.36%α −1.25% · $115.79
- T+5 · 4mo ago +10.68%α +11.67% · $129.93
- T+20 · 3mo ago +5.18%α +2.62% · $123.47
- T+60 · 5w ago −4.96%α −7.81% · $111.57
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two senior Incyte executives (CMO and EVP of U.S. Commercial) sold a combined $341K in open-market stock on July 16, 2026, at ~$115/share. This is a very small cluster relative to Incyte's $23.4B market cap (~0.0015%), making it economically trivial. The sales coincide with a large batch of non-cash equity grants to multiple executives on the same date, suggesting the sales are likely liquidity-driven to cover tax obligations or diversify after vesting, not a bearish signal on fundamentals.
Key Financial Metrics
Key Facts
- Two C-suite insiders sold a combined $341K in open-market shares on July 16, 2026.
- Total sales represent ~0.0015% of Incyte's $23.4B market cap, economically trivial.
- Sales occurred on the same day as large non-cash equity grants to multiple executives, consistent with tax-withholding or diversification after vesting.
- No insider open-market purchases were made in the cluster window.
Financial Impact
Total insider sales of $341K, representing ~0.0015% of market cap, immaterial.
Risk Factors
- Insider sales could increase if the stock appreciates further, but this is routine post-vesting behavior.
- No fundamental risk signaled by this cluster.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INCY-1784613996350 |
Track record
18 reports on INCY
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +23.70% at T+60 after the Jun 8, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $118.50 Now $120.27 +1.49% settles Feb 16
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $123.09 Now $120.27 −2.29% settles Feb 12
- Nov 13, 20263d ago 8-K Neutral 3/10 Entry $119.45 Now $120.27 +0.69% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $120.97 Now $120.27 −0.58% settles Feb 11
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $122.27 Now $120.27 −1.64% settles Feb 9
- Nov 6, 202610d ago 144 Neutral 4/10 Entry $121.89 Now $120.27 −1.33% settles Feb 5
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $122.85 Now $120.27 −2.10% settles Feb 2
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $116.80 Now $120.27 +2.97% settles Jan 27
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $115.71 Now $120.27 +3.94% settles Jan 21
- Aug 14, 202613w ago Insider Cluster Bearish 4/10 Entry $123.50 to $120.30 Now $120.27 +2.62% ▲ +2.59% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers